Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: Poland Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20183
20193
20206
20214
20226
20234
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
AstraZeneca3
GlaxoSmithKline3
Genmab2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Alnylam Pharmaceuticals1
Amgen1
Ascendis Pharma Oncology Division A/S1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Multiple Myeloma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2
Alzheimer Disease1
Biliary Tract Neoplasms1
Brain Neoplasms1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.